Literature DB >> 18239456

The pluripotency regulator Oct4: a role in somatic stem cells?

Christopher J Lengner1, G Grant Welstead, Rudolf Jaenisch.   

Abstract

Since its discovery as a critical regulator of pluripotency in embryonic stem (ES) cells and the inner cells mass of the developing blastocyst, the Pou domain-containing transcription factor Oct4 has become a proxy for "stemness" in numerous studies of somatic stem cells as its presence is often taken as evidence of pluripotency in these cells. Recent studies, however, have demonstrated that not only is Oct4 dispensable for maintaining potency in somatic stem cell compartments, but also that the methods applied to detect Oct4 and the interpretation of the resulting data may be flawed. Here we contrast pathways known to govern pluripotency in embryonic stem cells with those in adult stem cells and critically discuss the concept of pluripotency in adult stem cells of the mammalian soma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239456     DOI: 10.4161/cc.7.6.5573

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  49 in total

1.  Molecular cloning and production of caprine recombinant Oct4 protein for generation induced pluripotent stem cells.

Authors:  Dinesh K Singhal; Raxita Singhal; Hruda N Malik; Surender Singh; Sudarshan Kumar; Jai K Kaushik; Ashok K Mohanty; Dhruba Malakar
Journal:  Mol Biol Rep       Date:  2015-10-30       Impact factor: 2.316

Review 2.  The path from skin to brain: generation of functional neurons from fibroblasts.

Authors:  Aisha Iman Abdullah; Andrew Pollock; Tao Sun
Journal:  Mol Neurobiol       Date:  2012-05-22       Impact factor: 5.590

3.  More life for a "terminal" cell.

Authors:  Zea Borok; Edward D Crandall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

4.  Direct conversion of skin cells into blood: alchemy or science?

Authors:  Katherine Y King; Margaret A Goodell
Journal:  Mol Ther       Date:  2011-02       Impact factor: 11.454

5.  Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease.

Authors:  Aldrin E Molero; Solen Gokhan; Sara Gonzalez; Jessica L Feig; Lucien C Alexandre; Mark F Mehler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

6.  High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis.

Authors:  Kyungeun Kim; Hyojin Ihm; Jae Y Ro; Yong Mee Cho
Journal:  Oncol Lett       Date:  2011-08-02       Impact factor: 2.967

7.  A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells.

Authors:  P Dentelli; C Barale; G Togliatto; A Trombetta; C Olgasi; M Gili; C Riganti; M Toppino; M F Brizzi
Journal:  Diabetologia       Date:  2012-10-12       Impact factor: 10.122

8.  Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.

Authors:  Zoe Redshaw; Alastair J Strain
Journal:  J Negat Results Biomed       Date:  2010-03-31

Review 9.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

10.  Regulation of adipose tissue stromal cells behaviors by endogenic Oct4 expression control.

Authors:  Jung Hwan Kim; Min Ki Jee; So Young Lee; Tae Hee Han; Bong Sun Kim; Kyung Sun Kang; Soo Kyung Kang
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.